期刊文献+

含2,4-二氨基-6-(2′-吡嗪)-均三嗪及甘氨酸的铜(Ⅱ)配合物的合成、晶体结构及与DNA作用(英文) 被引量:5

Synthesis,Crystal Structure and DNA-Binding Properties of Copper(Ⅱ) Complex with 6-(Pyrazin-2′-yl)-1,3,5-triazine-2,4-diamine and Glycinate
下载PDF
导出
摘要 以2,4-二氨基-6-(2′-吡嗪)-均三嗪(PZTA)及甘氨酸为配体与高氯酸铜作用合成了配合物[Cu(H2O)(Gly)(PZTA)]ClO4(Gly=甘氨酸根)。通过元素分析、测定摩尔电导率、红外光谱和紫外可见光谱进行表征,并用单晶X-射线衍射方法测定了该配合物的晶体结构。配合物晶体属于单斜晶系,空间群C2/c,晶胞参数:a=2.189 6(3)nm,b=1.308 3(2)nm,c=1.465 4(4)nm,β=131.467(3)°,晶胞体积:V=3.145 6(9)nm3,晶胞内结构基元数:Z=8,Dc=1.876 g.cm-3,最后的残差因子:R1=0.037 4,wR2=0.100 9。应用紫外光谱、溴化乙锭荧光探针及粘度测定等方法研究了配合物与DNA的作用。结果表明,主题配合物以部分插入方式与DNA作用。 Abstract: The copper(H) complex [Cu(H20)(Gly)(PZTA)]C104 (Gly=glycinate) was prepared by the reaction of 6- (pyrazin-2'-yl)-l,3,5-triazine-2,4-diamine (PZTA) and glycine (Gly) with copper(I) perchlorate, and characterized by elemental analysis, infrared radiation, UV-Vis, and molar conductance. Its crystal structure was determined by single crystal X-ray diffraction method. The complex crystallizes in the monoclinic system, space group C2/c, with cell parameters: a=2.189 6(3) nm, b=1.308 3(2) rim, c=1.465 4(4) nm,/3=131.467(3)°, cell volume: V=3.145 6(9) nm3, number of molecules inside the cell: Z=8, final R indices (I〉2σ(I)): R1=0.037 4, wR2=0.100 9. The interaction of the complex to DNA was studied by UV spectroscopy, EtBr fluoescent probe and viscosity measurement. The results indicate that the complex could interact with DNA by partial intercalative mode. CCDC: 848150.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2012年第12期2667-2673,共7页 Chinese Journal of Inorganic Chemistry
基金 广东省自然科学基金(No.10151064201000016) 华南农业大学211工程重点项目(No.2009B010100001)资助项目
关键词 铜(Ⅱ)配合物 2 4-二氨基-6-(2′-吡嗪)-均三嗪 甘氨酸 晶体结构 脱氧核糖核酸 copper(Ⅱ) complex 6-(pyrazin-2'-yl)-l,3,5-triazine-2,4-diamine glycine crystal structure DNA
  • 相关文献

参考文献30

  • 1Garoufis A, Hadjikakou S K, Hadjiliadis N. Coord. Chem. Rev., 2009,253(9-10):1384-1397.
  • 2Patra A K, Roy S, Chakravarty A R. Inorg. Chim. Acta, 2009,362(13) :4692-4698.
  • 3Grueso E, Lopez-Perez G, Castellano M, et al. J. Inorg. Biochem., 2012,106(1):1-9.
  • 4Bencini A, Lippolis V. Coord. Chem. Rev., 2010,254(17-18): 2096-2180.
  • 5LU Yan-Mei(卢艳梅),LE Xue-Yi(乐学义).Wuji Huaxue Xuebao, 2011,27(2):199-213.
  • 6Yoshikawa Y, Komeda S, Uemura M, et al. Inorg. Chem., 2011,50(22): 11729-11735.
  • 7Ren X X, Chen J Y, Le X Y. Chin. J. Chem., 2011,29(7): 1380-1388.
  • 8Sasmal P K, Patra A K, Nesaji M, et al. lnorg. Chem., 2007, 46(26): 11112-11121.
  • 9HONG Xian-Lan(洪显兰),REN Jian-Min(任健敏).Wuji Huaxue Xuebao, 2011,27(4):785-790.
  • 10BIAN Lin(边琳),LI Lian-Zhi(李连之),WANG Xia(王霞),et al. Wuji Huaxue Xuebao, 2011, 27(4):649-654.

共引文献1

同被引文献92

  • 1扬频,高飞.生物无机化学原理[M].科学出版社,2002.
  • 2Gielen M,Wiley,Chichester.Metallotherapeutic drugs and metal-based diagnostic agents:the use of metals in medicine[J].2005,23(11):538-546.
  • 3彭斌,周文辉,严林,等.手性锰(ⅢⅡ)配合物与DNA相互作用研究[J].过渡金属化学,2009,34:231-237.
  • 4计亮年,莫庭焕.生物无机化学导论[M].中山大学出版社,1992,39-61,84-85,258-295.
  • 5Wang N X.Nuclear Magnetic Resonance Spectroscopy-Apphcation In Organic Chemistry,second edition[M].Beijing Chemical Industry Press,2010:25-26.
  • 6Breslow R,Overman I E.Artifical enzyme combining a metal catalytic group and a hydrophobic binding cavity[J].J.Am Chem Soc,1970,92(4):1075-1077.
  • 7JI Liang-Nian(计亮年), MAO Zong-Wan(毛宗万), HUANG Jin-Wang(黄锦汪), et al. 生命无机化学导论. Beijing: Science Press, 2010.
  • 8Jiang Q, Xiao N, Shi P F, et al. Coord. Chem. Rev., 2007, 251(15/16):1951-1972.
  • 9Bencini A, Lippolis V. Coord. Chem. Rev., 2010, 254(17/18): 2096-2180.
  • 10Sayen S, Carlier A, Tarpin M, et al. J. Inorg. Biochem., 2013, 120:39-43.

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部